Annual Meeting News

WHIPPANY, N.J.--(BUSINESS WIRE)--ASCO 2026: Bayer Shares New Findings for NUBEQA for Cognitive Decline in Men with aPC Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial...

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYX® (cabozantinib) provided significant improvements in progression-free survival (PFS) versus placebo in patients with previously treated advanced neuroendocrine tumors (NET) regardless of functional status. These data will be presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting to be held fr...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the latest results from its mission to build Multimodal Foundation Models at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. Tempus has been building novel biological foundation models and agentic workflows by leveraging its more than 500 petabytes of rich, molecularly grounded data—more than 45 million total de-identified...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced unprecedented seven-year follow-up results from the Phase 3 CROWN trial evaluating LORBRENA® (lorlatinib, a third-generation ALK inhibitor, available in Europe under the brand name LORVIQUA®) versus XALKORI® (crizotinib) in people with previously untreated, anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC). At seven years, patients treated with LORBRENA had a 55% likelihood of re...

SINGAPORE--(BUSINESS WIRE)--BW LPG Limited (“BW LPG” or the “Company”, OSE ticker code: “BWLPG.OL”, NYSE ticker code “BWLP”) advises that the 2026 Annual General Meeting was held on 28 May 2026 at 11:30am Singapore time at 10 Pasir Panjang Road, Mapletree Business City #18-01, Singapore 117438. The following resolutions were passed: To adopt the Directors’ Statement, Audited Financial Statements and the Auditor’s Report. To re-elect the following persons as Directors: Mr. Andreas Sohmen-Pao Ms....

RICHMOND, Va.--(BUSINESS WIRE)--CarMax, Inc. (NYSE:KMX) will report its financial results for the first quarter ended May 31, 2026 before the market opens on June 17, 2026, and it will host a conference call with investors at 8:00 a.m. ET to discuss these results. Please note that the Company has changed the time of its earnings conference calls to 8:00 a.m. ET. Participants on the call will include Keith Barr, President and CEO, Enrique Mayor-Mora, Executive Vice President, CFO and Jon Daniels...

DALLAS--(BUSINESS WIRE)--Matador Resources Company (NYSE: MTDR) (“Matador” or the “Company”) will hold its 2026 Annual Meeting of Shareholders on Thursday, June 11, 2026, at 9:30 a.m. Central Time. The Annual Meeting will be held at Hilton Dallas Lincoln Centre, 5410 LBJ Freeway, Dallas, Texas 75240. A continental breakfast will be provided beginning at 8:30 a.m. Central Time to provide shareholders with the opportunity to meet and interact with directors, management and employees before and af...

TORCÉ, France--(BUSINESS WIRE)--Regulatory News: Groupe OKWIND (FR0013439627 – ALOKW), which is specialized in the design, manufacture and sale of smart energy generation and management systems dedicated to self-consumption, informs its shareholders that its Combined General Meeting will be held at the Company's headquarters, in the Zone du haut Montigné, 214 rue du Pont Samoual, 35370 - Torcé, on Thursday June 11, 2026 at 10 am. To attend the General Meeting, it is required to be in possession...

NEW YORK--(BUSINESS WIRE)--TWO Announces Adjournment of Special Meeting...